企業プロフィール
Angion Biomedica 株価・ニュース・カタリスト
- ティッカー:
- ANGN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for ANGN.
企業概要
事業概要
Angion Biomedica was a development-stage biotech focused on kidney disease, inflammation, and organ-protection biology. Its story was built around a narrow set of programs trying to create value in hard-to-treat indications.
所在地とセクター分類
Angion was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotechnology with a translational medicine profile.
ビジネスモデルの特徴
The company depended on clinical progress, target validation, and capital management to keep programs moving. Investors typically focused on early readouts, pipeline prioritization, and whether the biology could support a durable asset.
バイオ業界での位置付け
Angion occupied a classic small-cap biotech niche where a limited pipeline and limited runway made the stock highly sensitive to data and financing.
今後のカタリスト
- Angion Biomedica is a legacy / closeout story, with catalysts limited to any residual asset or corporate update. There is no active standalone pipeline driving the name.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。